Skip to main content
. 2023 Oct 24;14:1238667. doi: 10.3389/fimmu.2023.1238667

Table 3.

Summary of TRAEs.

Total
(n = 59) No. (%)
Cohort A
(n = 31)
No. (%)
Cohort B
(n = 28)
No. (%)
Any 59 (100) 31 (100) 28 (100)
Grade ≥ 3 39 (66.1) 21 (67.7) 18 (64.3)
Serious TRAEs 23 (39.0) 10 (32.3) 13 (46.4)
Led to treatment discontinuation 7 (11.9) 4 (12.9) 3 (10.7)
Led to death 3 (5.1) 2 (6.5) 1 (3.6)

TRAE, treatment-related adverse event.